Naftifine warnings and precautions: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Naftifine}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NAFTIN (NAFTIFINE HYDROCHLORIDE) CREAM [MERZ PHARM...")
 
No edit summary
 
Line 3: Line 3:
{{CMG}}; {{AE}} {{AZ}}
{{CMG}}; {{AE}} {{AZ}}


==Warnings==


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = NAFTIN (NAFTIFINE HYDROCHLORIDE) CREAM [MERZ PHARMACEUTICALS, LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af | publisher =  | date =  | accessdate =  }}</ref>
Naftin® Cream and Gel, 1% are for topical use only and not for ophthalmic use.


==Precautions==
===General===
Naftin® Cream and Gel, 1%, are for external use only. If irritation or sensitivity develops with the use of Naftin® Cream or Gel, 1%, treatment should be discontinued and appropriate therapy instituted. Diagnosis of the disease should be confirmed either by direct microscopic examination of a mounting of infected tissue in a solution of potassium hydroxide or by culture on an appropriate medium.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = NAFTIN (NAFTIFINE HYDROCHLORIDE) CREAM [MERZ PHARMACEUTICALS, LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af | publisher =  | date =  | accessdate =  }}</ref>
==References==
==References==
{{Reflist}}
{{Reflist}}

Latest revision as of 03:37, 9 January 2014

Naftifine
Naftin® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Warnings

Naftin® Cream and Gel, 1% are for topical use only and not for ophthalmic use.

Precautions

General

Naftin® Cream and Gel, 1%, are for external use only. If irritation or sensitivity develops with the use of Naftin® Cream or Gel, 1%, treatment should be discontinued and appropriate therapy instituted. Diagnosis of the disease should be confirmed either by direct microscopic examination of a mounting of infected tissue in a solution of potassium hydroxide or by culture on an appropriate medium.[1]

References

  1. "NAFTIN (NAFTIFINE HYDROCHLORIDE) CREAM [MERZ PHARMACEUTICALS, LLC]".

Adapted from the FDA Package Insert.